Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay

被引:66
|
作者
Calaf, Raymond [1 ]
Cerini, Claire [2 ]
Genovesio, Cecile [1 ]
Verhaeghe, Pierre [7 ,8 ,9 ]
Jourde-Chiche, Noemie [2 ,3 ]
Berge-Lefranc, David [4 ]
Gondouin, Bertrand [2 ,3 ]
Dou, Laetitia [2 ]
Morange, Sophie [5 ]
Argiles, Angel [6 ]
Rathelot, Pascal [7 ,8 ,9 ]
Dignat-George, Francoise [2 ]
Brunet, Philippe [2 ,3 ]
Charpiot, Philippe [1 ,2 ]
机构
[1] Univ Mediterranee, Lab Biochim Mol Fondamentale & Clin, UFR Pharm, F-13385 Marseille 5, France
[2] Univ Mediterranee, UMR INSERM 608, UFR Pharm, F-13385 Marseille 5, France
[3] Hop Conception, AP HP, Ctr Nephrol & Transplantat Renale, F-13005 Marseille, France
[4] Univ Mediterranee, Unite Chim Phys Prevent Risques & Nuisances Techn, UFR Pharm, F-13385 Marseille 5, France
[5] Hop Conception, Ctr Invest Clin, INSERM, F-13005 Marseille, France
[6] Ecole Natl Super Chim, RD Nephrol & Grp Rein & HTA, EA3127, Inst Univ Rech Clin IURC UM1, F-34090 Montpellier, France
[7] Univ Aix Marseille 1, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[8] Univ Aix Marseille 2, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[9] Univ Aix Marseille 3, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 23期
关键词
Chronic kidney disease; Uremic solutes; Ion-pairing HPLC; P-CRESYL SULFATE; INDOXYL SULFATE; TOXINS; SERUM; INDUCTION; MORTALITY; CRESYLSULPHATE; PLASMA; PHENOL;
D O I
10.1016/j.jchromb.2011.06.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
During chronic kidney disease (CKD), solutes called uremic solutes, accumulate in blood and tissues of patients. We developed an HPLC method for the simultaneous determination of several uremic solutes of clinical interest in biological fluids: phenol (Pol), indole-3-acetic acid (3-IAA), p-cresol (p-C), indoxyl sulfate (3-INDS) and p-cresol sulfate (p-CS). These solutes were separated by ion-pairing HPLC using an isocratic flow and quantified with a fluorescence detection. The mean serum concentrations of 3-IAA, 3-INDS and p-CS were 2.12, 1.03 and 13.03 mu M respectively in healthy subjects, 3.21, 17.45 and 73.47 mu M in non hemodialyzed stage 3-5 CKD patients and 5.9, 81.04 and 120.54 mu M in hemodialyzed patients (stage 5D). We found no Pol and no p-C in any population. The limits of quantification for 3-IAA, 3-INDS, and p-CS were 0.83, 0.72, and 3.2 mu M respectively. The within-day CVs were between 1.23 and 3.12% for 3-IAA, 0.98 and 2% for 3-INDS, and 1.25 and 3.01% for p-CS. The between-day CVs were between 1.78 and 5.48% for 3-IAA, 1.45 and 4.54% for 3-INDS, and 1.19 and 6.36% for p-CS. This HPLC method permits the simultaneous and quick quantification of several uremic solutes for daily analysis of large numbers of samples. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:2281 / 2286
页数:6
相关论文
共 50 条
  • [1] Uremic Solutes in Chronic Kidney Disease and Their Role in Progression
    van den Brand, Jan A. J. G.
    Mutsaers, Henricus A. M.
    van Zuilen, Arjan D.
    Blankestijn, Peter J.
    van den Broek, Petra H.
    Russel, Frans G. M.
    Masereeuw, Rosalinde
    Wetzels, Jack F. M.
    PLOS ONE, 2016, 11 (12):
  • [2] Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight
    Chao, Chia-Ter
    Lin, Shih-Hua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [3] Uremic toxicity and sclerostin in chronic kidney disease patients
    Desjardins, Lucie
    Liabeuf, Sophie
    Oliveira, Rodriguo B.
    Louvet, Loic
    Kamel, Said
    Lemke, Horst-Dieter
    Vanholder, Raymond
    Choukroun, Gabriel
    Massy, Ziad A.
    NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (06): : 463 - 470
  • [4] Chronic kidney disease and fibrosis: the role of uremic retention solutes
    Mutsaers, Henricus A. M.
    Stribos, Elisabeth G. D.
    Glorieux, Griet
    Vanholder, Raymond
    Olinga, Peter
    FRONTIERS IN MEDICINE, 2015, 2
  • [5] The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease
    Koppe, Laetitia
    Fouque, Denis
    Soulage, Christophe O.
    TOXINS, 2018, 10 (04):
  • [6] Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
    Deltombe, Olivier
    Van Biesen, Wim
    Glorieux, Griet
    Massy, Ziad
    Dhondt, Annemieke
    Eloot, Sunny
    TOXINS, 2015, 7 (10): : 3933 - 3946
  • [7] The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial
    Poesen, Ruben
    Evenepoel, Pieter
    de Loor, Henriette
    Delcour, Jan A.
    Courtin, Christophe M.
    Kuypers, Dirk
    Augustijns, Patrick
    Verbeke, Kristin
    Meijers, Bjorn
    PLOS ONE, 2016, 11 (04):
  • [8] Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
    Moradi, Hamid
    Sica, Domenic A.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 38 (02) : 136 - 148
  • [9] Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3-4 Chronic Kidney Disease Patients
    Mutsaers, Henricus A. M.
    Engelke, Udo F. H.
    Wilmer, Martijn J. G.
    Wetzels, Jack F. M.
    Wevers, Ron A.
    van den Heuvel, Lambertus P.
    Hoenderop, Joost G.
    Masereeuw, Rosalinde
    PLOS ONE, 2013, 8 (08):
  • [10] Uremic toxins and chronic kidney disease complications
    Liabeuf, S.
    Drueke, T. B.
    Massy, Z. A.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (03): : 238 - 246